BRACHYDACTYLY, TYPE E2
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Deletion and point mutations of PTHLH cause brachydactyly type E.
|
20170896 |
2010 |
Malignant neoplasm of breast
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
First, a report in Nature Genetics identified the PTHrP locus as a new breast cancer susceptibility gene.
|
22546075 |
2012 |
Malignant neoplasm of breast
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We replicated previously reported breast cancer susceptibility alleles in these BRCA2 mutation carriers and for several regions (including FGFR2, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.
|
23544012 |
2013 |
Malignant neoplasm of breast
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Hypercalcemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, whereas control animals routinely developed hypercalcemia due to PTHrP production, treatment with PSP-94 led to a near normalization of plasma calcium and a marked reduction in PTHrP production as determined by radioimmunoassay and immunohistochemistry.
|
12727822 |
2003 |
Hypercalcemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Twenty-one patients with EPNS were detected: 16 with ectopic Cushing's syndrome (ECS), one with hypercalcaemia due to parathyroid hormone-related protein (PTHrP) secretion, three with hypercalcitonaemia and one patient with dual secretion of calcitonin and beta-human chorionic gonadotropin (β-HCG).
|
30280284 |
2019 |
Hypercalcemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Two heterozygous PTH/PTH-related peptide (PTHrP) receptor missense mutations were previously identified in patients with Jansen's metaphyseal chondrodysplasia (JMC), a rare form of short limb dwarfism associated with hypercalcemia and normal or undetectable levels of PTH and PTHrP.
|
10487664 |
1999 |
Hypercalcemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Although hypercalcemia due to PTHrP secretion has been published before, overproduction of calcitriol has not been reported yet in pediatric squamous cell skin carcinoma cases.
|
31782950 |
2019 |
Hypercalcemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Engineered from PTHrP (1-34), abaloparatide was made stable and overcame the loss of the anabolic window and hypercalcemia associated with TPTD.
|
31136739 |
2019 |
Hypercalcemia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
These results demonstrate that certain pancreatic neuroendocrine tumors associated with hypercalcemia can synthesize and release PTHrP.
|
2394507 |
1990 |
Breast Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
First, a report in Nature Genetics identified the PTHrP locus as a new breast cancer susceptibility gene.
|
22546075 |
2012 |
Breast Carcinoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We replicated previously reported breast cancer susceptibility alleles in these BRCA2 mutation carriers and for several regions (including FGFR2, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.
|
23544012 |
2013 |
Mammary Neoplasms
|
0.400 |
GeneticVariation
|
group |
BEFREE |
In light of these previous data, we have examined whether substrates of either reconstituted basement membrane or representative collagen components of the breast tumor stroma (type I, V and OF/LB) might (i) regulate the PTHrP promoter usage and mRNA splicing patterns, (ii) modulate quantitatively the extracellular release of immunoreactive PTHrP (iPTHrP), and (iii) affect the expression of PTHrP-R.
|
10606734 |
1999 |
Brachydactyly
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
We studied a family with autosomal-dominant Brachydactyly Type E (BDE) and identified a t(8;12)(q13;p11.2) translocation with breakpoints (BPs) upstream of PTHLH on chromosome 12p11.2 and a disrupted KCNB2 on 8q13.
|
20015959 |
2010 |
Brachydactyly
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Deletion and point mutations of PTHLH cause brachydactyly type E.
|
20170896 |
2010 |
Brachydactyly
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
The PTHLH gene encodes a parathyroid hormone-related protein (PTHrP) that is involved in the regulation of endochondral bone development, and mutations in this gene cause the type E form of brachydactyly.
|
25801215 |
2015 |
Brachydactyly
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Isolated brachydactyly type E (BDE), characterized by shortened metacarpals and/or metatarsals, consists in a small proportion of patients with Homeobox D13 (HOXD13) or parathyroid-hormone-like hormone (PTHLH) mutations.
|
31283647 |
2019 |
Brachydactyly
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Disease-causing variants and haploinsufficiency of PTHLH are known to cause brachydactyly type E and short stature.
|
26733284 |
2016 |
Brachydactyly
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Report of two novel mutations in PTHLH associated with brachydactyly type E and literature review.
|
26640227 |
2016 |
Brachydactyly
|
0.180 |
GeneticVariation
|
disease |
BEFREE |
Sanger sequencing of PTHLH revealed a novel heterozygous frameshift mutation c.258delC(p.N87Tfs*18) in two affected individuals and one relative manifesting mild brachydactyly.
|
26763883 |
2016 |
Dwarfism
|
0.140 |
GeneticVariation
|
disease |
BEFREE |
Disease-causing variants and haploinsufficiency of PTHLH are known to cause brachydactyly type E and short stature.
|
26733284 |
2016 |
Dwarfism
|
0.140 |
GeneticVariation
|
disease |
BEFREE |
In this study, we successfully identified a novel heterozygous mutation of the parathyroid hormone-like hormone (PTHLH) gene by exome sequencing in a Chinese pedigree with brachydactyly and short stature.
|
25801215 |
2015 |
Dwarfism
|
0.140 |
GeneticVariation
|
disease |
BEFREE |
Thus, loss-of-function mutations in PTHLH cause BDE with short stature.
|
20170896 |
2010 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Hypercalcemia is most commonly associated with primary hyperparathyroidism and malignancy due to parathyroid hormone-related protein (PTHrP).
|
8060769 |
1994 |